Paratek Pharmaceuticals
PRTK
$2.23
Share price
0.00%
Change (1 day)
15.54%
Change (1 year)
Categories
P/S ratio for Paratek Pharmaceuticals (PRTK)
P/S ratio as of May 2024 (TTM): 0.7621
According to Paratek Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.762057. At the end of 2023 the company had a P/S ratio of 0.7547.
P/S ratio history for Paratek Pharmaceuticals from 2006 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 0.7547 | 9.55% |
| 2022 | 0.6889 | -63.02% |
| 2021 | 1.86 | -71.62% |
| 2020 | 6.57 | -32.33% |
| 2019 | 9.70 | 0.35% |
| 2018 | 9.67 | -75.61% |
| 2017 | 39.6 | -99.67% |
| 2016 | > 1000 | |
| 2015 | N/A | -100% |
| 2014 | 128 | 253.23% |
| 2013 | 36.2 | 380.78% |
| 2012 | 7.54 | 40.03% |
| 2011 | 5.38 | -32.4% |
| 2010 | 7.96 | -54.44% |
| 2009 | 17.5 | 2625.33% |
| 2008 | 0.6412 | -85.86% |
| 2007 | 4.54 | -98.61% |
| 2006 | 326 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Ultragenyx RARE | 8.27 | 985.26% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | 8.22 | 978.21% | 🇺🇸 USA |
 Agenus
AGEN | 1.68 | 120.66% | 🇺🇸 USA |